Literature DB >> 28439723

Psychiatric comorbidity in alcohol use disorders: results from the German S3 guidelines.

U W Preuss1,2, E Gouzoulis-Mayfrank3, U Havemann-Reinecke4, I Schäfer5, M Beutel6, E Hoch7, K F Mann8.   

Abstract

Alcohol use disorders (AUD) have a high comorbidity with mental disorders. Vice versa, alcohol consumption plays an important role in affective disorders, anxiety disorders, ADHD, schizophrenic psychosis, and other mental disorders. In developing the current interdisciplinary, evidence-based treatment guideline on screening, diagnostics, and treatment of AUD, available research on comorbid mental diseases in AUD has been compiled to generate recommendations for treatment. The guideline was prepared under the responsibility of the German Association for Psychiatry, Psychotherapy, and Psychosomatics (DGPPN) and the German Association for Addiction Research and Therapy (DG-Sucht). To meet the methodological criteria for the highest quality guidelines ("S3-criteria") as defined by the Association of Scientific Medical Societies in Germany (AWMF), the following criteria were employed: (1) a systematic search, selection, and appraisal of the international literature; (2) a structured process to reach consensus; and (3) inclusion of all relevant representatives of future guideline users. After assessing and grading the available literature, the expert groups generated several recommendations for the screening, diagnosis, and treatment of comorbid mental disorders. These recommendations were subdivided into psycho-, pharmaco-, and combination therapies. These are the first guidelines ever to make specific treatment recommendations for comorbid mental diseases in AUD. The recommendations extend to different treatment approaches including diagnostics and settings to present available effective and state-of-the-art treatment approaches to clinicians. Hitherto, many clinical constellations have not been addressed in research. Therefore, recommendations for future research are specified.

Entities:  

Keywords:  Alcohol-related disorders; Comorbidity; Mental disorders; Substance use disorders; Treatment practice guidelines

Mesh:

Year:  2017        PMID: 28439723     DOI: 10.1007/s00406-017-0801-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  37 in total

1.  A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence.

Authors:  Roger D Weiss; Margaret L Griffin; Monika E Kolodziej; Shelly F Greenfield; Lisa M Najavits; Dennis C Daley; Heidi Ray Doreau; John A Hennen
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

2.  Comorbidity of social anxiety disorder and antisocial personality disorder in the National Epidemiological Survey on Alcohol and Related Conditions (NESARC).

Authors:  Todd Galbraith; Richard G Heimberg; Shuai Wang; Franklin R Schneier; Carlos Blanco
Journal:  J Anxiety Disord       Date:  2013-12-14

3.  The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization.

Authors:  R C Kessler; C B Nelson; K A McGonagle; M J Edlund; R G Frank; P J Leaf
Journal:  Am J Orthopsychiatry       Date:  1996-01

4.  Meta-analysis of supplemental treatment for depressive and anxiety disorders in patients being treated for alcohol dependence.

Authors:  Jennifer D J Hobbs; Matt G Kushner; Susanne S Lee; Sean M Reardon; Eric W Maurer
Journal:  Am J Addict       Date:  2011-05-31

Review 5.  A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders.

Authors:  A L Baker; S A Hiles; L K Thornton; L Hides; D I Lubman
Journal:  Acta Psychiatr Scand       Date:  2012-05-26       Impact factor: 6.392

6.  The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC).

Authors:  S Bernardi; S V Faraone; S Cortese; B T Kerridge; S Pallanti; S Wang; C Blanco
Journal:  Psychol Med       Date:  2011-08-16       Impact factor: 7.723

7.  Comorbidity of alcohol dependence with attention-deficit hyperactivity disorder: differences in phenotype with increased severity of the substance disorder, but not in genotype (serotonin transporter and 5-hydroxytryptamine-2c receptor).

Authors:  Monika Johann; Gabriela Bobbe; Albert Putzhammer; Norbert Wodarz
Journal:  Alcohol Clin Exp Res       Date:  2003-10       Impact factor: 3.455

8.  Atomoxetine treatment of adults with ADHD and comorbid alcohol use disorders.

Authors:  Timothy E Wilens; Lenard A Adler; Margaret D Weiss; David Michelson; Janet L Ramsey; Rodney J Moore; Didier Renard; Kathleen T Brady; Paula T Trzepacz; Leslie M Schuh; Lisa M Ahrbecker; Louise R Levine
Journal:  Drug Alcohol Depend       Date:  2008-04-09       Impact factor: 4.492

9.  A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders.

Authors:  E Sherwood Brown; Monica Garza; Thomas J Carmody
Journal:  J Clin Psychiatry       Date:  2008-05       Impact factor: 4.384

10.  Investigating the efficacy of integrated cognitive behavioral therapy for adult treatment seeking substance use disorder patients with comorbid ADHD: study protocol of a randomized controlled trial.

Authors:  Katelijne van Emmerik-van Oortmerssen; Ellen Vedel; Maarten W Koeter; Kim de Bruijn; Jack J M Dekker; Wim van den Brink; Robert A Schoevers
Journal:  BMC Psychiatry       Date:  2013-05-10       Impact factor: 3.630

View more
  6 in total

1.  Alert out on tobacco and alcohol consumption in young European women.

Authors:  Florence Thibaut
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-06       Impact factor: 5.270

2.  Translational research as prerequisite for personalized psychiatry.

Authors:  Martin E Keck; Nils Kappelmann; Johannes Kopf-Beck
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-04       Impact factor: 5.270

3.  Psychiatric comorbidities in alcohol use disorder.

Authors:  Alvaro Castillo-Carniglia; Katherine M Keyes; Deborah S Hasin; Magdalena Cerdá
Journal:  Lancet Psychiatry       Date:  2019-10-17       Impact factor: 27.083

Review 4.  Pharmacotherapeutic management of co-morbid alcohol and opioid use.

Authors:  Lauren E Hood; Jonna M Leyrer-Jackson; M Foster Olive
Journal:  Expert Opin Pharmacother       Date:  2020-02-27       Impact factor: 3.889

Review 5.  Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies.

Authors:  Joost J Breeksema; Alistair R Niemeijer; Erwin Krediet; Eric Vermetten; Robert A Schoevers
Journal:  CNS Drugs       Date:  2020-09       Impact factor: 5.749

Review 6.  Concurrent Disorder Management Guidelines. Systematic Review.

Authors:  Syune Hakobyan; Sara Vazirian; Stephen Lee-Cheong; Michael Krausz; William G Honer; Christian G Schutz
Journal:  J Clin Med       Date:  2020-07-28       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.